EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current Advances in Paraptosis Inducer Development and Mechanistic Understanding for Anticancer Applications

Chen Shen iD, Xiaoxiao Zhang, Yawen Zhao, Shouxin Liu

Drug Development Research · 2026

DOI: 10.1002/ddr.70260 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, 2026. Verfasst von Chen Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical & Pharmaceutical Engineering, Hebei University of Science & Technology, Shijiazhuang, China. Hauptthemen laut MEDLINE: Paraptosis, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 161 Literaturangaben. Gefördert von: National Basic Research Program of China, National Natural Science Foundation of China, Natural Science Foundation of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paraptosis is an emerging form of programmed cell death (PCD) that is distinct from conventional cell death modalities such as apoptosis, autophagy, necrosis, and pyroptosis. It is characterized by dilation of the endoplasmic reticulum (ER) and/or mitochondria, accompanied by extensive cytoplasmic vacuolation. This process has garnered significant interest within the realm of cancer treatment in recent years. Therefore, this review provides a comprehensive summary of the potential mechanisms underlying paraptosis and highlights recent progress in the development of paraptosis inducers for cancer therapy. These inducers include natural products, synthetic compounds, and anticancer drugs; moreover, they are frequently employed in combination with other therapeutic strategies. Furthermore, these inducers can trigger paraptosis in cancer cells via multiple pathways, thereby providing a promising alternative therapeutic approach for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParaptosisAntineoplastic AgentsNeoplasmsHumansAnimalsBiological ProductsApoptosisEndoplasmic ReticulumMitochondria

Stichwörter der Autor:innen

cancer therapycytoplasmic vacuolationparaptosisprogrammed cell death

Substanzen

Antineoplastic AgentsBiological Products

Autor:innen und Institutionen

  • College of Chemical & Pharmaceutical Engineering, Hebei University of Science & Technology, Shijiazhuang, China.
  • State Key Laboratory Breeding Base-Hebei Province Key Laboratory of Molecular Chemistry for Drug, Hebei Collaborative Innovation Center of New Drug Creation, Hebei University of Science & Technology, Shijiazhuang, China.

ORCID-Profile: Chen Shen

Förderung

  • National Basic Research Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hebei Province

Zitieren

APA

Shen, C., Zhang, X., Zhao, Y., & Liu, S. (2026). Current Advances in Paraptosis Inducer Development and Mechanistic Understanding for Anticancer Applications. Drug Development Research. https://doi.org/10.1002/ddr.70260

Vancouver

Shen C, Zhang X, Zhao Y, Liu S. Current Advances in Paraptosis Inducer Development and Mechanistic Understanding for Anticancer Applications. Drug Development Research. 2026. doi:10.1002/ddr.70260

BibTeX
@article{Shen2026,
  author = {Shen, Chen and Zhang, Xiaoxiao and Zhao, Yawen and Liu, Shouxin},
  title = {Current Advances in Paraptosis Inducer Development and Mechanistic Understanding for Anticancer Applications},
  journal = {Drug Development Research},
  year = {2026},
  doi = {10.1002/ddr.70260}
}
Kostenlos starten →